Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Developer of a cloud-native, API-first software and data platform designed to deliver better and data-driven outcomes. The company automates critical back office operations and powers digital wealth management ecosystems, enabling registered investment advisors, TAMPs, financial institutions, and FinTech innovators to align essential wealth data, proactive client insights, and reporting to deliver a truly personalized client experience and to power next-generation wealth management applications.